CJ Corp., Hanmi dispute trademark

Published: 2004-10-26 07:00:00

Updated: 2004-10-26 07:00:00

Hanmi Pharm said it has refused to honor the Korean Intellectual Property Office's decision to grant CJ's trademark Simvasta (simvastatin), noting that the recognition of such trademark similar to a generic name will affect other trademarks imitating generic names.

Market observers said Hanmi ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK